(Q34627903)

3 August 2017

1 reference

title

Human CYPs: in vivo and clinical aspects (English)

1 reference

3 August 2017

Olavi Pelkonen

1

1 reference

PubMed ID

11996010

3 August 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

3 August 2017

Drug Metabolism Reviews

1 reference

3 August 2017

34

1 reference

3 August 2017

37-46

1 reference

3 August 2017

1-2

1 reference

Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors

3 August 2017

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001388

Pharmacogenetics: the slow, the rapid, and the ultrarapid

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001388

Inhibition and induction of human cytochrome P450 (CYP) enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001388

Induction and drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001388

Interindividual variability in inhibition and induction of cytochrome P450 enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001388

CYP2A6: a human coumarin 7-hydroxylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001388

Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001388

Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail".

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001388

Clinically significant pharmacokinetic interactions between dietary caffeine and medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001388

Is diclofenac a valuable CYP2C9 probe in humans?

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001388

Biochemistry and molecular biology of the human CYP2C subfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001388

21 January 2018

Human cytochromes P-450.

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001388

Cytochrome P-4502E1: its physiological and pathological role

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001388

Cytochrome P4503A (CYP3A) metabolism: prediction of in vivo activity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001388

Effects of the antifungal agents on oxidative drug metabolism: clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001388

Enzyme induction and inhibition by new antiepileptic drugs: a review of human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001388

Cytochrome P-450 3A4: regulation and role in drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001388

Antipyrine as a model drug to study hepatic drug-metabolizing capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001388

In vitro approaches can predict human drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001388

Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001388

21 January 2018

Identifiers

DOI

10.1081/DMR-120001388

1 reference

3 August 2017

1 reference

PubMed ID

11996010